Author

Carrie Qi Sun

Emory University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Adegboyega K. OyelereiD· 1 shared Alexis JohnstoniD· 1 shared Bocheng WuiD· 1 shared Dan Gabriel DudaiD· 1 shared David A. GauliD· 1 shared Jeremiah Olorunjuwon OlugbamiiD· 1 shared John A. PetrosiD· 1 shared Rebecca S. Arnold· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adegboyega K. OyelereORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy

Bocheng Wu, Subhasish Tapadar, Zhiping Ruan, Carrie Qi Sun, Rebecca S. Arnold, Alexis Johnston, Jeremiah Olorunjuwon Olugbami, Uche Okuu Arunsi, David A. Gaul, John A. Petros, Tatsuya Kobayashi, Dan Gabriel Duda, Adegboyega K. Oyelere

This paper identifies a novel HDAC inhibitor, STR-V-53, that effectively targets HCC and enhances immunotherapy responses in mouse models.

ACS Pharmacology & Translational Science · Sep 5, 2024Peer-reviewedCancer Biology